Investors
Grant-funded, then seed-funded
Pre-clinical research was funded by grants from The National Institutes of Health, the Massachusetts Life Sciences Center and the Partners HealthCare Innovation Fund.
In August 2014, ProteoThera closed on a $3.1 million seed investment by the Gradus Fund.
At a glance
- Seed round$3.1M, Aug 2014
- Lead investorGradus Fund
- Grant supportNIH, MLSC, PIF
NIH
Pre-clinical research was funded by grants from The National Institutes of Health.
Massachusetts Life Sciences Center
Pre-clinical research was funded by grants from the Massachusetts Life Science Center.
Partners HealthCare Innovation Fund
Pre-clinical research was funded by grants from the Partners Healthcare Innovation Fund.
Gradus Fund
In August 2014, ProteoThera closed on a $3.1 million seed investment by the Gradus Fund.
Backers
On the company’s own page
